n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, April 4th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

3PEA International, Inc. (TPNL)

The Next Hot Stock, Volcano Stocks, OtcWizard, FeedBlitz, HyperSpeedStocks, and Nebula Stocks reported on 3PEA International, Inc. (TPNL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

3PEA International, Inc. is a vertically integrated provider of inventive prepaid card programs and processing services. These are for corporate, consumer, and government applications. By way of its PaySign® brand, the Company designs and develops payment solutions, prepaid card programs, and customized payment services. 3PEA International is based in Henderson, Nevada.

3PEA International is a payment processor and debit card program manager. The Company manages programs for many of the world’s largest pharmaceutical manufacturers with copay assistance products designed to maximize new patient acquisition, retention, and adherence. 3PEA International’s customers include healthcare companies, major pharmaceutical companies and source plasma providers, large multinationals, prestigious universities, and social media companies.

3PEA’s customizable prepaid solutions provide considerable cost savings. This is while improving brand recognition and customer loyalty. The Company has launched the PaySign® brand of prepaid cards. This includes solutions for corporate incentives, payroll, public sector, pharmaceutical co-pay assistance, source plasma donations, general spend reloadable, and other market niches.  

3PEA International has an increased presence in the plasma donation payments space through signing The Interstate Companies and B Positive National Blood Services. In addition, it has partnered with Haemonetics to integrate the PaySign® Connect prepaid card solution with Haemonetics' Donor Management System. Also, 3PEA entered into an agreement with Visa, whereby 3PEA exclusively issues Visa-branded prepaid cards for the PaySign® brand.

The Company has expanded its PaySign® brand of prepaid cards to the automotive market with PaySign Connect for Automobile Dealerships. The extensive PaySign Connect prepaid solution is a customizable, multi-purpose platform tailored to the unique needs of auto dealerships.

Via the PaySign platform, 3PEA International provides an array of services. These include transaction processing, cardholder enrollment, value loading, cardholder account management, reporting, and customer service. The Company divides prepaid cards into two general categories. One is corporate and consumer reloadable. The other is non-reloadable cards.

Last week, 3PEA International reported financial results for Q4 and the full year ended December 31, 2016. Financial highlights for 2016 in comparison to 2015 include Revenues increasing 28 percent to a record $10.4 million. Gross Profit grew to $5.2 million, or 50 percent of total revenue, versus $4.1 million, or 50 percent of total revenue in 2016.

Net Income grew to $1.4 million, or $0.03 per diluted share, versus a (loss) of ($2.4 million), or $(0.06) per share. This represents an increase of $3.6 million, or $0.09 per diluted share. The Company surpassed 1,000,000 PaySign Cardholders.

3PEA International, Inc. (TPNL), closed Tuesday's trading session at $0.4002, down 4.71%, on 55,950 volume with 18 trades. The average volume for the last 60 days is 40,609 and the stock's 52-week low/high is $0.1499/$0.47.

5BARz International, Inc. (BARZ)

Innovative Marketing, Stock Commander, AllPennyStocks, OTC Markets Group, PennyStocks24, Tip.us, Wyatt Investment Research, StockRockandRoll, StockBomb.com, StockLockandLoad, Beacon Equity Research, Penny PayDay, Penny Stocks Finder, Stock Preacher, Stock Roach, StockHideout, and TheLightningPicks reported earlier on 5BARz International, Inc. (BARZ), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

5BARz International, Inc. is a technology leader in the cellular network extender industry. The Company centers on the worldwide commercialization of a patented product technology branded under the name 5BARz™.  5BARz™ is a cellular network infrastructure device for use in the small office, home, or for when users are mobile. 5BARz International’s unique product is the 5BARz Network Extender™. 5BARz International is based in San Diego, California and the Company lists on the OTCQB.

5BARz established a wholly-owned subsidiary Company, 5BARz India Private Ltd., in Bangalore, India. 5BARz India is a wholly-owned subsidiary of 5BARz. It is licensed the exclusive rights to market and distribute all 5BARz products across India in perpetuity. 5BARz India earlier commenced commercial rollout of the 5BARz™ Network Extender in India.

5BARz™ represents an important solution for cellular network operators in providing clear, high quality signal for their subscribers with an increasing need for high quality connectivity. Its products include the 5BARz Network Extender and the 5BARz Road Warrior.

5BARz™ incorporates a patented technology to create a highly engineered, single-piece, plug 'n play unit. It strengthens weak cellular signals to deliver high quality signals for voice, data, and video reception on cell phones and other cellular equipped devices.

The above-mentioned 5Barz Network Extender™ is a “carrier grade” cellular network infrastructure device. It can be remotely managed from each carrier’s Network Operation Center.

The 5Barz Network Extender™ includes patented technologies, including bringing together the send and receive antenna into a single form factor, automatically cancels echo or “noise cancellation”, and supports multiple bands and all frequencies globally. In addition, it automatically balances power management to avoid any interference with the macro network. It can also support up to ten simultaneous users at a time.

Last September, 5BARz International announced that 5BARz India Private Limited entered the wireless router business via its advanced next generation Wi-Fi broadband router and smart home hub, which brings in new innovations for the homes in developing markets. This new product comes with intuitive features and state-of-the-art functionalities. These will now enable Wi-Fi users to smartly monitor, manage, as well as control their home networks while at home or away.

In February 2017, 5BARz International announced that 5BARz India Private Limited unveiled its advanced next generation 5BARz™ ‘ROVR’ Wi-Fi Router & Smart IoT Hub at an event held at its Bangalore offices. 5BARz India will immediately begin rolling out the product in the Indian market as a part of its exclusive contract with a leading Internet Service Provider (ISP) to connect 5 million Indian homes to the Internet over the next 5 years.

5BARz International, Inc. (BARZ), closed Tuesday's trading session at $0.0494, up 0.82%, on 225,599 volume with 13 trades. The average volume for the last 60 days is 522,936 and the stock's 52-week low/high is $0.0446/$0.12.

Cellceutix Corp. (CTIX)

AllPennyStocks, The Observer, Stock Gumshoe, Promotion Stock Secrets, Streetwise Reports, StreetAuthority Financial, INO.com Market Report, Weekly Wizards, Market Authority, PennyStocks24, Pennybuster, OTC Showcase, Money Morning, FeedBlitz, and Real Pennies reported earlier on Cellceutix Corp. (CTIX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cellceutix Corp. is developing innovative therapies with oncology, dermatology, and anti-inflammatory and antibiotic applications. A clinical stage biopharmaceutical enterprise, Cellceutix has established research collaborations with world-renowned research institutions in the U.S. and Europe. These include the MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna. Cellceutix has its corporate office in Beverly, Massachusetts.

Cellceutix’s anti-cancer drug Kevetrin (a Novel p53-modulating drug candidate) concluded a Phase 1 clinical trial at Harvard Cancer Centers' Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. The Company is in a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention of Oral Mucositis in patients with head and neck cancer. Its anti-psoriasis drug Prurisol completed a Phase 2 trial. Prurisol is a small molecule that acts via immune modulation and PRINS reduction.

Cellceutix's lead antibiotic, Brilacidin, has completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections (ABSSSI). Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the Food and Drug Administration (FDA)-approved seven-day dosing regimen of daptomycin. Brilacidin has the potential to be a single-dose therapy for certain multi-drug resistant bacteria.

Recently, Cellceutix announced progression of its continuing Phase 2 clinical trial of Brilacidin to the third cohort (highest dose) for induction of remission of mild-to-moderate ulcerative colitis after satisfactory safety of prior cohorts was reported by the study’s Safety Committee.  Patients included those with Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS), two types of Inflammatory Bowel Disease (IBD). Patients continued to tolerate the treatment well in Cohort B, echoing comments from patients in Cohort A by reporting improvements in quality of life.

This month, Cellceutix stated that based on positive results from its Phase 1 trial of Kevetrin in solid tumors conducted at Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center, it is moving forward with a Phase 2 trial of intravenously-administered Kevetrin in patients with late-stage, platinum-resistant ovarian cancer.

Moreover, this month, Cellceutix announced more favorable topline findings as part of interim analysis from its ongoing Phase 2a Proof-of-Concept (PoC) study of Brilacidin for the treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS).

Last week, the Company presented positive results from its continuing randomized, double-blind Phase 2 study of Brilacidin in the prevention and control of Oral Mucositis (OM) in patients receiving chemoradiation for the treatment of Head and Neck Cancer. In a preliminary interim analysis, a clear reduction in incidence of Severe OM (WHO Grade > 3) was observed in patients treated with Brilacidin who received at least 55 Gy cumulative units of radiation.

Cellceutix’s American Association of Cancer Research (AACR) Poster presented data supporting Kevetrin modulation of p53 in multiple human ovarian cancer cell-lines and corresponding xenograft tumors. Key findings which were presented today include transcriptomic analyses, demonstrating Kevetrin modulation of p53 signaling pathways; and induction of cell cycle arrest and apoptosis in Ovarian Cancer cell-lines and in xenograft tumors. The Company presented today at the AACR Annual Meeting, in Washington, D.C.

Cellceutix Corp. (CTIX), closed Tuesday's trading session at $0.96, down 0.52%, on 152,248 volume with 71 trades. The average volume for the last 60 days is 276,397 and the stock's 52-week low/high is $0.86/$1.87.

iAnthus Capital Holdings, Inc. (ITHUF)

We are reporting on iAnthus Capital Holdings, Inc. (ITHUF) today, here at the QualityStocks Daily Newsletter.

iAnthus Capital Holdings, Inc. is a provider of capital investment and management services to licensed cannabis cultivators, processors, and dispensaries throughout the U.S. The Company, by way of its 100 percent owned subsidiary, iAnthus Capital Management, LLC, delivers a complete solution for financing and managing these enterprises. iAnthus Capital Holdings has its head office in New York, New York. The Company also has an office in Toronto, Ontario.

iAnthus supports a diversified portfolio of cannabis industry investments. It provides a unique combination of capital and practical operating and management expertise. Entrepreneurs with decades of experience in investment banking, corporate finance, law, and healthcare services founded the Company.

So far, iAnthus Capital Holdings has invested in finance and management partnerships in 4 states, potentially consisting of 8 licenses, 9 dispensaries, as well as 4 cultivation facilities. The Company has developed strategic partnerships with best-in-class industry-sector leaders in dispensary operations, commercial-scale cannabis cultivation, regulatory law, and the science of cannabis product formulation and testing.

iAnthus creates agreements, which create valuable partnerships. The Company remains hands-on with its investments. It works with its partners to optimize opportunities, overcome hurdles, and maximize value.

iAnthus applies thorough analysis to ascertain the very best business prospects in each market across the U.S. The Company’s present portfolio includes Grassroots Vermont; Mayflower Medicinals, Inc.; Organix, Breckenridge Colorado; and R. Greenleaf Organics.

Last month, iAnthus Capital Holdings announced that construction started on a state-of-the-art cannabis cultivation and processing facility in Holliston, Massachusetts for the benefit of Mayflower Medicinals, Inc. Mayflower is a Massachusetts non-profit Registered Marijuana Dispensary (RMD) license holder affiliated with iAnthus.

Yesterday, iAnthus Capital Holdings announced that it has obtained eligibility with The Depository Trust Company (DTC) for its common shares listed on the OTC Markets Group’s OTCQB. DTC is a subsidiary of the Depository Trust & Clearing Corp. DTC manages the electronic clearing and settlement of share transactions for publicly-traded companies. Furthermore, iAnthus announced that it is pursuing electronic eligibility (DWAC/FAST) that permits DTC participants to deposit stock into a brokerage account electronically.

iAnthus Capital Holdings, Inc. (ITHUF), closed Tuesday's trading session at $2.00, down 6.80%, on 39,802 volume with 27 trades. The average volume for the last 60 days is 8,028 and the stock's 52-week low/high is $1.0879/$2.7953.

ImMAGE Biotherapeutics Corp. (IMMG)

Marketwatch, Bloomberg, Investorshub.com, and Thestockmarketwatch reported on ImMAGE Biotherapeutics Corp. (IMMG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

ImMAGE Biotherapeutics Corp. is an early-stage biotechnology company. The Company formed in 2015 to harness the power of the human immune system to treat cancer. ImMAGE is developing multiple viable candidates to treat triple-negative breast cancer (TNBC). It has progressed from in-vitro trials to animal testing. ImMAGE’s pipeline is built from a proprietary immunotherapy, which can be used alone and in strategic combinations to develop novel, disease-specific therapies that enhance the body's immune response to treat cancers.

ImMAGE Biotherapeutics has offices in Bethesda, Maryland, and Philadelphia, Pennsylvania, and it’s a subsidiary of PepVax, Inc. The Company’s shares trade on the OTC Markets’ OTCQB.

ImMAGE has a method, which allows for the fast development of important cancer immunotherapy candidates. These could be licensed to the biotechnology and pharmaceutical industry, giving them the opportunity to develop in vitro proven treatments, establishing credibility of ImMAGE’s rapid development model.

The Company develops targeted therapeutics for the treatment of tumors that expresses the Melanoma antigen family – A (MAGE-A) antigen. This growing portfolio of treatment targets using one universal vaccine gives it the advantage of centering on tumors that have not had viable treatments and yet cuts cost as it is one therapy.

The MAGE-A antigen is a cancer test expressed within the human testes. It is highly immunogenic. It has been considered as a viable target for the development of immunotherapies of tumors overexpressing the MAGE-A family of antigens. The MAGE-A sub-family of cancer testis antigen is expressed in germ cells, although not exclusively.

ImMAGE Biotherapeutics began in vitro verification experiments for efficacy in October 2015. In January 2016, the Company announced the addition of new candidates to the pipeline, while advancing 8 candidates into final in vitro trials for testing of expression. In June of 2016, ImMAGE successfully completed its in vitro trials and commenced designing in vivo studies. Next, it moved two more candidates into in vivo trials.

This past February, ImMAGE Biotherapeutics announced its completion of the YEi Start in France program. The YEi Start in France program is an accelerator designed to help entrepreneurs grow their business in France and Europe.  ImMAGE was one of eight U.S. companies chosen to complete an intensive one week immersion in France in December 2016, which provided introductions to a wide-ranging customized business network and connections to the best resources in Europe.

Last week, ImMAGE Biotherapeutics announced that its immunotherapy successfully passed early toxicology and efficacy studies. After four weeks of treatment in transgenic mice, the lead candidate was able to show very little toxicity in a full toxicology report of different organs.

ImMAGE Biotherapeutics Corp. (IMMG), closed Tuesday's trading session at $1.12, even for the day, on 7,900 volume with 5 trades. The average volume for the last 60 days is 165,905 and the stock's 52-week low/high is $0.10/$1.62.

graphic

The QualityStocks
Company Corner

graphic
graphic

Bollente Companies, Inc. (BOLC)

The QualityStocks Daily Newsletter would like to spotlight Bollente Companies, Inc. (BOLC). Today, Bollente Companies, Inc. closed trading at $0.65, up 41.30%, on 2,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 8,821 and its 52-week low/high is $0.20/$1.07.

Bollente Companies, Inc. today announced that its trutankless line of smart electric tankless water heaters is the exclusive water heating solution for luxury communities built by the award-winning Arizona home builder Cullum Homes. Cullum Homes, known for its high level of craftsmanship and energy-efficient building methods, is the exclusive builder for The Village at Mountain Shadows in Paradise Valley and The Village at Silverleaf in North Scottsdale. Both communities offer luxury amenities like guard-gated entries, smart home technology, resort settings and the finest in architectural design and craftsmanship. With numerous awards and accolades for its patented design, smart home compatibility and energy efficiency, trutankless was selected to be the standard water heater for every home in both communities.

Bollente Companies, Inc. (BOLC) is in the early stages of developing a diverse portfolio of companies, targeting disruptive technologies that positively impact the environment and emerging economies. Their current focus is on high-efficiency electric tankless water heaters, manufactured and sold under "trutankless", a division of Bollente, including a line of economy tankless water heaters sold under the Vero name. Units are available for both residential and commercial application.

The primary Bollente advantage is their use of advanced technology, superior to previous tankless systems, together with a growing U.S. and global market. Traditional water heaters are one of the costliest appliances to operate. The two primary energy sources used in U.S. homes are electric and natural gas, with less than half of U.S. homes having natural gas available. In addition, there are no significant electric whole home tankless manufacturers.

The U.S. Department of Energy now requires tanks of 55 gallons or more to have efficiency levels requiring expensive heat pumps to achieve. Bollente's trutankless electric tankless water heater employs specialized sensors for constant water temperature, solid state electronics, and proprietary software, resulting in one of the most efficient heat exchangers ever produced. The technology includes smart grid and home automation capabilities, remote control and monitoring, and even smartphone alerts. It also allows adjustable custom power management settings, so that users can further enhance energy usage and performance. It is now estimated that tankless heaters used in every home would save over $8 billion annually in the U.S. alone.

By maintaining 99 percent efficiency, Bollente's trutankless heaters use less energy than tank heaters, while providing the convenience of always-hot water. The system only uses power when there is demand, producing water to exact temperature, within one degree, even with sudden changes to input. Wireless apps allow for remote settings, notifications, and monitoring, and models are compatible with existing home automation and energy management systems. The technology also reduces size, for easy location, and the system's self-flushing design provides up to 20+ years of maintenance free operation, significantly reducing upkeep and replacement costs. This becomes an additional environmental benefit since roughly 8 million used water heaters are dumped in landfills every year.

Bollente has also announced the formation of Bollente International, Inc., a wholly-owned subsidiary, for the international production and sale of trutankless systems. Taking advantage of growing interest in their technology, Bollente International is working with an international manufacturing firm for the production and distribution of trutankless systems throughout Europe, Asia, Australia and New Zealand, with the first step being the testing and certification necessary to meet the various international standards.

Bollente has made electric tankless water heating compelling to a major consumer market, both in and outside the U.S., offering economic as well as operational efficiency and convenience, attractive to builders as well as to end consumers. Disclaimer

Bollente Companies, Inc. Blog

Bollente Companies, Inc. News:

Award-Winning Luxury Builder Cullum Homes Makes trutankless® the Exclusive Water Heating Solution in its Communities

Bollente Companies, Inc. (BOLC) is “One to Watch”

Second Generation of Trutankless® Smart Water Heaters to Be Unveiled At International Builders Show

CD International Enterprises, Inc. (CDII)

The QualityStocks Daily Newsletter would like to spotlight CD International Enterprises, Inc. (CDII). Today, CD International Enterprises, Inc. closed trading at $0.0214, up 38.06%, on 1,460,740 volume with 107 trades. The stock’s average daily volume over the past 60 days is 634,691 and its 52-week low/high is $0.0001/$56.00.

CD International Enterprises, Inc. (CDII) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.CD International Enterprises, Inc., CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

CD International Enterprises, Inc. Blog

CD International Enterprises, Inc. News:

CD International Enterprises Enters Agreement to Distribute Cannabidiol (CBD) in the United States

CD International Enterprises Enters Consulting Agreement with Zhangjianjie Shengshi Agricultural Development Company, Limited

CD International Enterprises Enters Corporation Agreement With Everbright Investment and Construction Company, Limited

ProBility Media Corp. (PBYA)

The QualityStocks Daily Newsletter would like to spotlight ProBility Media Corp. (PBYA). Today, ProBility Media Corp. closed trading at $0.727, up 34.01%, on 200 volume with 1 trade. The stock’s average daily volume over the past 60 days is 1,447, and its 52-week low/high is $0.1205/$1.16.

ProBility Media Corp. (PBYA) based in Houston, TX, is an EdTech Company that is building the first full service training and career advancement brand for the skilled trades. Through both acquisitions and organic growth, ProBility is executing a disruptive strategy of defragmenting the market place of disparate companies servicing fifteen vertical categories in over sixty skilled trades. ProBility has positioned itself as a key industrial training resource for individuals, small- and medium-size businesses as well as enterprise customers offering consistent high-quality training services and materials for education, testing, and career advancement.

Through its Electrical Training Division, the company has become the biggest wholesaler of electrical codes and test preparation materials in the U.S., while its Construction Training Division is one of the largest certification providers in the country, with programs in 22 states, and continuing to grow. The company serves corporate accounts and government buyers, and also offers advisory services for companies of all sizes.

Companies currently under the ProBility Media conglomerate include:

  • Brown Technical Media Corp. – An online web business with multiple micro web sites featuring training materials and codes and standards sought by engineers, construction workers, scientists and other tradesmen in a wide variety of fields.
  • Brown Technical Publications – A proprietary publishing business generating copyrighted training materials for engineers, construction workers, scientists and other tradesman in a wide variety of fields.
  • 1ExamPrep – E-Learning, education and exam preparation for contractors via the cheapest, fastest and most effective exam prep school in the industry instituting our 4-point proven learning system.
  • National Electrical Wholesale Providers – In the business of distributing wholesale industrial, commercial and residential training materials including HVAC, plumbing and electrical.

ProBility's technology platform features virtual reality training for the crane business to be expanded into other industries, online subscription services for enterprise level companies, and recurring revenue streams. In addition, the company is already beginning to explore international expansion options, supported by the fact that other countries have adopted U.S. based codes, and have used U.S. training services.

The company's acquisition strategy targets operations that service engineering firms, electrical contractors, fabricators, plumbing contractors, pipe fitters, riggers, QC firms, and additional vocational industries. Disclaimer

ProBility Media Corp. Company Blog

ProBility Media Corp. News:

ProBility Media Corp. Files 10Q, Reports Third Consecutive Quarter of Revenue Growth

ProBility Media Corp. and GlobalSim Inc. Join Forces to Introduce Virtual Reality Training to the Crane Industry

ProBility Media Corp. Announces Philanthropic Initiative

eXp World Holdings, Inc. (EXPI)

The QualityStocks Daily Newsletter would like to spotlight eXp World Holdings, Inc. (EXPI). Today, eXp World Holdings, Inc. closed trading at $3.74, up 3.03%, on 12,751 volume with 23 trades. The stock’s average daily volume over the past 60 days is 10,603, and its 52-week low/high is $1.15/$5.84.

eXp World Holdings, Inc. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.

Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.

Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.

Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer

eXp World Holdings, Inc. Company Blog

eXp World Holdings, Inc. News:

eXp World Holdings, Inc. (OTCQB: EXPI) Reports 137% Revenue Growth in FY16, Record Q4

eXp World Holdings to Present at The MicroCap Conference on April 4th in New York

eXp Realty Reaches 3,000 Agent Milestone

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX). Today, ChineseInvestors.com closed trading at $1.255, up 2.03%, on 95,233 volume with 67 trades. The stock’s average daily volume over the past 60 days is 180,439 and its 52-week low/high is $0.12/$2.75.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com Blog

ChineseInvestors.com News:

ChineseInvestors.com Announces Investment in Breakwater MB, LLC a Cannabis-Focused Investment and Consulting Company

Alan Klitenic, Director of Investor Relations for ChineseInvestors.com, Discusses Recent CIIX News and Industry Trends in a New Audio Interview with SmallCapVoice.com

ChineseInvestors.com Launches XiBiDi Biotechnology to Reach China's 1.4 Billion Consumer Base

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

StockMarketWatch
(TGC) +79.49%

2.

Monster Alerts
(EMAV) +45.45%

3.

QualityStocks
(BOLC) +41.30%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251